Dr. Michael Sweeney, MD

Dr. Sweeney practices at Norton Children's Infusion Center - HOPD in Louisville, Kentucky.

Dr. Sweeney's NPI, 1235455494, was assigned on April 13, 2010. Dr. Sweeney graduated from Medical College Of Wisconsin in 2010. Dr. Sweeney holds Kentucky license 48882.

Dr. Sweeney's primary practice is Norton Children's Infusion Center - HOPD, at 411 E Chestnut St, Louisville, KY 40202.

Dr. Sweeney's primary practice is Norton Children's Infusion Center - HOPD in Louisville, Kentucky. Dr. Sweeney is also affiliated with Norton Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Sweeney to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sweeney practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Sweeney's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Sweeney is board certified in neurology with special qualification in child neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Sweeney's licenses on file in 4 states: Kentucky, Indiana, Utah and Ohio.

Dmand AI lists multiple sclerosis and neuropathy among the conditions Dr. Sweeney treats.

CMS data shows 16 Medicare services from Dr. Sweeney across 1 procedure code in 2024, all of them office visits, for 19 Medicare patients. Medicare paid $1,138 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 19 Medicare patients who saw Dr. Sweeney in 2024. 58% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sweeney's median patient age at 18, with 60% women.

In 2024, Dr. Sweeney wrote 793 Medicare Part D claims for 52 patients. 85% of them were for generic drugs. CMS names the drug for 634 of them, across 27 drugs with 11 or more claims each, at $978,372 in total drug cost. In 2023, CMS named 442 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sweeney for performance year 2024, reported as part of a group. Dr. Sweeney accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Sweeney, published from 2014 to 2022. 2021 was the busiest year, with 3. The most frequent topics are Autoantibodies, Brain and Magnetic Resonance Imaging. Dr. Sweeney has published most often in Pediatr Neurol. Dr. Sweeney's most frequent co-authors are Stacey L. Clardy, MD, PhD, Justin Ralph Abbatemarco, MD and Christopher Ryan Barton, MD.

CMS Open Payments shows 240 general payments to Dr. Sweeney from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Genentech, Inc. paid the most, $85,107. It also lists 1 research payment totaling $5,402 in 2021.

Dmand AI lists 1 award for Dr. Sweeney, most recently James T. Lubin Fellowship in 2016.

Dr. Sweeney graduated from Medical College Of Wisconsin in 2010. Dr. Sweeney is a member of AAN and Child Neurology Society.

Dr. Sweeney is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.